A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess Injection Site Relative Bioavailability Of Pf-04950615 Following Subcutaneous Administration In Adult Subjects With Hypercholesterolemia
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2015
At a glance
- Drugs Bococizumab (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 05 Jan 2015 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
- 09 Oct 2014 Planned End Date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.
- 09 Oct 2014 Planned primary completion date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov record.